olink service Provider

Quantitative proteomics for biomarker discovery

With 10 years of Olink proteomics experience, we deliver fast, accurate protein biomarker data, accelerating your research and drug development.

High-throughput proteomics

As a designated Olink service provider, we excel in quantifying proteins to provide an in-depth biological understanding of disease and drug response.

Olink technology is based on Proximity Extension Assay (PEA). PEA enables high-throughput, multiplex immunoassays of proteins using minimal volumes of serum, plasma, or almost any other type of biological sample.

Each antibody pair in the assay is tagged with unique DNA reporter sequences. After an antibody pair binds to a protein, the reporter DNA sequences are amplified by real-time PCR, generating quantitative data of the proteins detected simultaneously.

The explorative Olink panels measure the concentration of thousands of human plasma proteins using small samples, covering all major biological and disease-relevant pathways.

With Olink® Explore 3072, you can access the entire Olink protein library of approximately 3,000 protein assays for exploratory proteomics and multiomics studies. You can choose one or several of the eight Explore 384-plex panels covering inflammation, oncology, neurologic, and cardiometabolic pathways for more focused projects, comprising the Explore 3072 library.

The Olink Target 96 panels specialize in key disease areas and essential biological processes to accelerate targeted protein biomarker research. Olink provides the following panels: Target 48 Cytokine, Target 96 Cardiovascular, Target 96 Immuno-Oncology, Target 96 Neurology, and Target 96 Oncology.

Olink also provides custom panels with custom targets or flex panels, enabling the selection and combination of custom panels with already thoroughly prevalidated protein biomarkers.


TATAA Biocenter has over 10 years of experience running Olink studies, and we have an experienced team delivering our premium service, providing high-quality reliable data.

To become a Olink service provider we were required to pass special Olink training, and process thousands of samples.

We offer the full breadth of Olink panels and with the sequencing and PCR analysis all done in-house, projects are easy to manage and quicker to deliver with short lead times.

compliant bioanalysis

Accurate and reproducible data

A GLP accredited and GCLP compliant laboratory

TATAA Biocenter is accredited by the Swedish Board of Accreditation and Conformity Assessment (SWEDAC) for complying with Good Laboratory Practice (GLP) standards. We also adhere to Good Clinical Laboratory Practice (GCLP) guidelines, which are international quality standards governing the analysis of samples from clinical trials using GLP.

GLP and GCLP validation is mandatory in preclinical and clinical assays to demonstrate accuracy, reliability, and consistency. These standards cover every aspect of study planning, execution, monitoring, documentation, archiving, and reporting. This rigorous process assures both the sponsors, when submitting data for new drug approvals, and the regulatory authorities, when reviewing the data, that it is generated in a regulated manner.

drug development TATAA Biocenter
Lines in Circle Mask - Lg
method validation

Accelerate drug development with validated assays

Validated bioanalysis is essential throughout the entire drug development process.

Conducting fit-for-purpose validations in the initial stages of discovery is key. These validations offer valuable insights of expected assay performance before undertaking more comprehensive method validation processes. A validated PCR assay is essential to ensure the accuracy and reliability of results and ensures that the assay meets the client’s needs, study requirements, and assay criteria under defined operating conditions. Our assay validations ensure dependable data for making stage-gate decisions and preparing regulatory filings.

A validated assay is a valuable asset.

The Olink Target 96 panels are designed for high throughput, cost efficiency, and low sample consumption, facilitating targeted biomarker research in various disease areas and biological processes. The Olink Target 96 panels simultaneously enable high-multiplex targeting analysis of 92 protein

The Olink Explore 384 panels collectively form the comprehensive Explore 3072 panel. Run one or several of these panels on each sample simultaneously. Each Olinke 384 panel contains carefully selected proteins validated for human plasma and serum samples, making it

The Explore HT panel contains over 5,400+ proteins, almost twice as many as the Explore 3072 panels. The sample volume for Explore HT is 2 µl, compared to 6 µl for Explore 3072. The workflow for Explore HT is four

why work with tataa?

The power of our approach

Committed to quality, innovation, and fostering strong client relationships, we serve as your trusted partner to accelerate drug development. As a contract research organization, we are committed to generating accurate and reproducible data that shortens time-to-market.

Experienced scientists

We are ahead of industry trends and always updated on the regulatory landscape and requirements for gene editing and nucleic acid-based therapies. Our purpose is to provide data that’s easily auditable.

Total project transparency

We maintain transparency and proactively communicate throughout the project, ensuring our clients always stay updated on the progress. Transparency forms the cornerstone of our proven client model.

Have confidence in your data

We use the highest quality reagents, adhere to dedicated controls, and standardize all processes per technical requirements like the MIQE guidelines. We deliver rapid, robust, and reproducible results that are submission ready.

Flexible and scalable

Every project is customized to meet our client’s specific needs. We manage projects of all sizes and all stages, including any or all phases from sample extraction to analysis and data transfer. Your goals are our deliverables.


We operate with the latest technologies

TATAA Biocenter comprises highly skilled scientists with extensive expertise in method development, optimization, validation, and optimization of molecular analysis. We leverage market-leading instrumentation and automation platforms, offering expert guidance to choose the most suitable technology for your program.

PCR Analysis TATAA Biocenter

We use highly sensitive and highly precise quantitative PCR (qPCR) and digital PCR (dPCR) technologies to detect one or multiple DNA/RNA targets in complex samples.

NGS Services TATAA Biocenter

We use NGS, a powerful tool to sequence entire exomes, genomes, or transcriptomes, and our scientists and bioinformaticians provide comprehensive sequencing data.

Quantitative proteomics

We are a designated Olink service provider with the latest technologies for running quantitative proteomics using Olink’s panels for biomarker discovery, validation, and screening.

contact US

Let's explore how we can support your drug development program

PK/PD​ bioanalysis

General Olink Page

"*" indicates required fields